Corebridge Financial Inc. Sells 2,532 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Corebridge Financial Inc. lessened its position in HCA Healthcare, Inc. (NYSE:HCA) by 4.9% during the 4th quarter, Holdings Channel reports. The firm owned 48,932 shares of the company’s stock after selling 2,532 shares during the quarter. Corebridge Financial Inc.’s holdings in HCA Healthcare were worth $14,687,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in HCA. Whipplewood Advisors LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $31,000. Tidemark LLC bought a new position in HCA Healthcare in the 4th quarter valued at $36,000. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare during the third quarter worth approximately $39,000. Activest Wealth Management lifted its holdings in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after buying an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. increased its stake in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Bank of America dropped their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. Morgan Stanley dropped their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Truist Financial dropped their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, KeyCorp cut their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $336.12 on Wednesday. The stock has a market cap of $82.75 billion, a P/E ratio of 15.30, a P/E/G ratio of 1.10 and a beta of 1.68. The company has a fifty day moving average price of $322.63 and a two-hundred day moving average price of $341.89. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the business earned $5.90 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.86%. HCA Healthcare’s payout ratio is presently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.